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ABSTRACT 
The pH (Low) Insertion Peptides (pHLIP
®
 peptides) find application in studies of membrane-
associated folding, since spontaneous insertion of these peptides is conveniently triggered by 
varying pH. Here we employed small angle X-ray scattering (SAXS) to investigate WT pHLIP
®
 
peptide oligomeric state in solution at high concentrations and monitor changes in liposome 
structure upon peptide insertion into the bilayer. We established that even at high concentrations 
(up to 300 µM) WT pHLIP
®
 peptide at pH 8.0 does not form oligomers higher than tetramers 
(which exhibit concentration-dependent transfer to monomeric state as it was shown previously). 
This finding has significance for medical applications, when high concentration of the peptide is 
injected into blood and diluted in blood circulation. The interaction of WT pHLIP
®
 peptide with 
liposomes does not alter the unilamellar vesicle structure upon peptide adsorption by lipid 
bilayer at high pH or upon insertion across the bilayer at low pH. At the same time, SAXS data 
clearly reflect the insertion of the peptide into the membrane at low pH, which opens the 
possibility to investigate kinetic process of a polypeptide insertion and exit from the membrane 
in real time by time-resolved SAXS. 
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Introduction 
Folding and insertion into membrane of constitutive membrane proteins is facilitated by 
complex molecular machines in vivo, including the translocon that places most transmembrane 
(TM) helices across the bilayer (1-3). While they are assisted in their pathways by the Get 
proteins(4), non-constitutive membrane proteins (such as tail-anchored proteins) can 
spontaneously insert and fold themselves across the lipid bilayer of a membrane. They may do so 
when released by the Get complex in vivo (5, 6). The molecular mechanisms of spontaneous 
polypeptide folding/insertion and exit/unfolding are of interest in several contexts including the 
action of antimicrobial peptides, the folding and degradation of membrane proteins, and 
biotechnological/medical applications based on these processes.  
Stability and folding of all membrane proteins, irrespective of mechanism of their insertion into 
membrane, are governed by the formation of polypeptide secondary structures in the lipid bilayer 
environment, driven by the hydrophobic interactions and by hydrogen bonding. A convenient 
experimental approach is to trigger a coil-helix transition and peptide insertion into a bilayer by a pH 
jump. The protonation enhances the hydophobicity of the peptide and, therefore, its affinity to the 
nonpolar environment of a membrane. One such case of a synthetic peptide with pH-dependent 
membrane-insertion properties has been investigated by White and Ladokhin (7). Another example is the 
pH Low Insertion Peptide (pHLIP
®
 peptides) family, which is the subject of this study.  
The wild type (WT) pHLIP
®
 peptide was derived from the C-helix of bacteriorhodopsin (8, 9). 
Later, many different pHLIP
®
 variants were introduced (10-15). All peptides share the same 
property: pH-dependent insertion into lipid bilayer of membrane, which is accompanied by a 
coil-helix transition and formation of a transmembrane (TM) helix. Importantly, the main 
principle of membrane-associated folding was employed to introduce a novel class of rationally 
designed pHLIP
®
 delivery agents. The pHLIP
®
 peptides have medical utility, since they can 
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target acidic diseased tissues, such as tumors, and deliver therapeutic cargo molecules across 
membrane or target nanoparticles to cancer cells. Wide medical efficacy of pHLIP
®
 peptides 
were shown in imaging (16-21) and therapeutic (22-27) applications. 
The peptides of pHLIP
®
 family exhibit in three major states: the State I is attributed to the 
peptides in a coil conformation in aqueous solution at >pH7.4; if a membrane is introduced into 
the system, the peptides stay in equilibrium between aqueous free and membrane-bound states, 
which is called the State II. Finally, when pH is lowered (<pH6.0) the Asp/Glu residues in 
pHLIP
®
 peptides are protonated, which enhances peptide hydrophobicity and promotes peptide 
partition into bilayer, which is accompanied by folding. The system reaches minimum of free 
energy, when peptides adopt TM helical conformation, which is assigned to the State III. 
Thermodynamics and kinetics studies were carried to establish molecular mechanism of 
peptide’s adsorption by the bilayer (transition from State I to State II) and insertion into the 
membrane (transition from State II to State III) (10, 12, 28, 29). Our ultimate goal is to introduce 
physical model, which describes spontaneous insertion of a polypeptide into anisotropic 
environment of lipid bilayer and formation of a polypeptide helical structure. We already did 
first step, and proposed mathematical formalism describing coil-helix transition of a polypeptide 
adsorbed at the membrane (30). In order to introduce thermodynamics and kinetics models we 
have to get full knowledge about both conformational changes within a polypeptide and a 
membrane during peptide insertion and folding. In all previous studies the main emphasis was on 
monitoring of conformational changes, which occur in the pHLIP
®
 peptides. Here we used small 
angle x-ray scattering (SAXS) to monitor changes, which might occur within the lipid bilayer of 
POPC liposomes, when WT pHLIP
®
 peptide interacts with liposomes at high and low pH values. 
We selected to work with WT pHLIP
® 
peptide and POPC liposome system, since the system was 
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very intensively characterized previously and changes in SAXS signal could be attributed to 
particular events of peptide-membrane interactions. 
X-ray and neutron scattering methods have been widely used to elucidate the nanostructure of 
vesicles and oriented membranes (31-33). These techniques are sensitive to both membrane 
thickness perturbations and lateral inhomogeneities(31, 34). In the case of unilamellar vesicles, 
the mean radius, size polydispersity, average membrane thickness and internal membrane 
structure can be derived by means of the separated form factor model (35, 36). Here we have 
used SAXS over an extended size scale to monitor changes to the unilamellar vesicle form factor 
and membrane nanostructure.     
Experimental Procedures 
Peptides preparation 
WT pHLIP
®
 peptide (AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT) was 
synthesized and purified at W.M. KECK Biotechnology center at Yale. The synthesized peptide 
was dissolved directly in buffer and then centrifuged to remove large aggregates. Concentration 
of the peptide was calculated spectrophotometrically by measuring absorbance at 280 nm using 
extinction coefficient ɛ280 = 13,940 M
-1
 cm
-1
. 
 
Liposomes preparation 
Large unilamellar and multilamellar vesicles were prepared by extrusion. POPC, 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) was dissolved in chloroform, 
desolvated in a rotary evaporator and dried under high vacuum for several hours. The 
phospholipid film was then rehydrated in 10 mM phosphate buffer pH 8.0, vortexed until the 
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lipid bilayer was completely dissolved, and extruded 51 times through the membranes with 50 
nm pore sizes.  
 
Steady-state fluorescence and CD  
Steady-state fluorescence, circular dichroism (CD and OCD) measurements were carried out 
under a temperature control at 25C on a PC1 spectrofluorometer (ISS, Inc.) and MOS 450 
spectropolarimeter (Bio-Logic, Inc.), respectively. The concentration of the peptide and POPC 
lipids was 150 µM and 4.4 mM, respectively. Tryptophan fluorescence of the peptide was 
excited at 295 nm and recorded with the excitation and emission slits set at 1 nm. The polarizers 
in the excitation and emission paths were set at the “magic” angle (54.7o from the vertical 
orientation) and vertically (0
o
), respectively. Peptide CD spectra were recorded from 190 to 260 
nm (where no PMT saturation was observed) with 0.5 nm increment using a cuvette with an 
optical path length of 0.5 cm.  
 
Small Angle X-ray Scattering (SAXS)  
Synchrotron SAXS measurements were carried out at beamline ID02 of the ESRF in Grenoble, 
France (33). The incident x-ray wavelength (𝜆) was 0.995 Å and the sample-to-detector distances 
were 3 m and 1 m, covering a scattering vector range of 0.03 – 6 nm-1. The magnitude of the 
scattering vector, q, is defined as q=(4/)sin(/2), with 𝜃 the scattering angle.  Samples were 
contained in a temperature controlled (25C) flow through quartz capillary cell with a diameter 
of 1.8 mm. The measured two dimensional SAXS patterns were normalized to an absolute 
intensity scale using the standard procedure and azimuthally averaged to obtain the intensity 
profile as a function of q (33). Typical exposure time was 0.1 sec (with an incident flux of 10
13
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photons/sec) and 3-4 frames were acquired for each sample, which were subsequently averaged 
after excluding any possible radiation damage. The background buffer was also measured by the 
same procedure with 10 frames in each case. The averaged buffer background was subtracted 
from each averaged sample intensity profile to obtain the presented I(q) data. In different 
experiments, the concentration of the peptide was 150 or 300 µM, and POPC liposomes of 
nominal size of 50 nm was 4.4 or 8.8 mM. SAXS intensities were measured for original POPC 
liposomes and those incubated with peptide at pH 8.0 and 5.0, as well as peptide alone in buffer. 
In addition, we carried out measurements with 100 nm and 200 nm liposomes: the overall trend 
was the same, however their analysis is more complicated due to the presence of multilamellar 
structure.   
 
Analysis of SAXS data 
The background subtracted scattered intensity from a suspension of particulate system can be 
expressed as, 
)()()( 2 qSqFNqI           (1) 
 where N is the number of particles per unit volume, F(q)
2
 is the single particle scattering 
function whose amplitude is given by the Fourier transform of the radial electron density profile 
and S(q) is the structure factor describing the interaction between particles. In this study, the 
suspensions are relatively dilute (volume fraction less than 0.01) and the interaction between 
particles can be neglected corresponding to S(q)1. In the case of WT peptide in solution, F(q)2 
is described by a geometric shape (cylinder) with a homogeneous scattering contrast (33). For 
unilamellar vesicles, the radius R, polydispersity and the membrane internal structure can be 
simultaneously evaluated using the separated form factor model (31-33, 35, 36). The scattering 
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contrast is essentially coming from the bilayer region, within the separated form factor model, 
F(q,R) is described by,    
𝐹(𝑞, 𝑅) = 4𝜋𝑟𝑒 ∫ [𝜌(𝑟) − 𝜌𝑚]
sin[(𝑅+𝑟)𝑞]
(𝑅+𝑟)𝑞
(𝑅 + 𝑟)𝑑𝑟
𝑡/2
−𝑡/2
     (2) 
Where t is the bilayer thickness with the origin at the midplane (r=0), (r) is the radial electron 
density of the membrane and m that of the solvent, and re is the classical electron radius. By this 
definition, R is the distance from the center of the vesicle to the midplane of the bilayer. The(r) 
of phospholipid membrane is approximately described by three Gaussian functions 
corresponding to the head group regions on both sides and middle hydrophobic chains. (33, 36)  
𝜌(𝑟) = ∑ 𝜌𝑖 ∙ 𝑒𝑥𝑝 [−
(𝑟−𝑅𝑖)
2
2𝜎𝑖
2 ]
3
𝑖=1          (3) 
Where and are the electron densities of the lipid head group and chain regions, 
respectively, Ri is the distance from the center of the group to the bilayer midplane, and i is the 
width of the corresponding Gaussian function. The excess electron densities of head group and 
the hydrophobic chains from the buffer, mand m, are denoted by H, and C, 
respectively. Corresponding widths of the Gaussian function are represented by DH and DC, and 
the distance from the midplane of the bilayer to the center of head group as XH (33, 36). 
F(q,R) is given by the separated form factor within the thin shell assumption (35, 36).
 
However, real vesicles have a finite size distribution and Eq. (1) needs to be weighted over the 
size distribution, f(R), which in this case is assumed to be Schulz size distribution (33, 36). In 
addition, S(q)1 since the volume fraction of unilamellar vesicles is of the order of 0.01 and 
POPC is not charged.  
𝐼(𝑞) = 𝑁 ∫ 𝐹(𝑞, 𝑅)2

0
 𝑓(𝑅)𝑑𝑅          (4) 
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Model fits using Eq. (4) yields the mean radius (RV) and polydispersity (pV) of the unilamellar 
vesicles, size of the head group and tail regions and the corresponding electron densities. It is 
assumed that the same geometric shape of the vesicle is maintained but the height and widths of 
the three Gaussian functions in Eq. (3) change when peptide interacts with lipid bilayer of 
membrane.   
 
Results 
We employed SAXS to follow changes in the lipid bilayer of POPC liposomes induced by WT 
pHLIP
®
 peptide adsorption at pH 8.0 and insertion at pH 5.0. These experiments were carried out 
at much higher peptide and lipid concentrations (150 µM and 300 µM for peptides and 4.4 mM 
and 8.8 mM for POPC lipids) as compared to concentrations of peptides and lipids used before in 
biophysical studies. Previously we have shown that WT pHLIP
®
 peptide is monomeric in 
aqueous solution at pH 8.0 at concentration of 7 µM and less, however it oligomerizes and forms 
tetramers at concentration of 50 µM (37). Here we first measured CD, fluorescence and 
scattering profile of 150 and 300 µM of WT peptide at pH 8.0. The position of maximum of 
fluorescence spectrum of WT peptide is 341 nm (Figure 1), and is very similar to the values 
established previously for 50 µM of the peptide (37). CD spectrum shows negative signal at 232 
nm (Figure 2) characteristic of exciton formation. Exciton (sharing of electronic density) is 
observed, when rings of several aromatic residues form stacks (38). The exciton formation was 
monitored previously for 50 µM of the peptide (37). At the same time, we do not observe 
appearance of any elements of secondary structure for WT peptide at 150 µM at pH 8.0.  
SAXS measurements provided very similar results for 150 and 300 µM of WT pHLIP
®
 peptide 
at pH 8.0. Figure 3 shows the scattering of 300 µM of WT pHLIP
®
 peptide in solution of pH 8.0 
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and pH 5.0. The scattering curves can be described well by Eq. (1) with F(q)
2
 the scattering 
function of polydisperse cylinders (33) and S(q) 1. Although a solid cylinder or disk may not be 
the exact geometrical form the peptide oligomers adopt in solution, the model serves to indicate 
the approximate lateral dimensions and association states. The fit parameters including an 
additive constant background (IB) are summarized in Table 1.  
We employed the cylindrical model to   find the mean radius (RC) and the height (HC) of the 
cylinder describing scattering profile of WT pHLIP
®
 peptide in solution at pH 8.0 is about 1.37 
nm and 6.4 nm, respectively, which corresponds to the cylinder volume of about 38 nm
3
. If we 
assume coil configuration (which is supported by CD data) of N = 35 residues long WT pHLIP
®
 
peptide and take into account that the contour length per residue (established previously) L = 4.3 
Å or 0.43 nm (39-41), then the average end-to-end length of the coil can be estimated to be d = L 
√N = 2.5 nm. Then for spherical shape, the volume occupied by a single WT peptide in a random 
coil conformation is about 8.2 nm
3
. Thus, about 4 peptides in a random coil configuration can 
occupy volume of about 33-44 nm
3
 depending on the packing parameter. It is an interesting and 
important finding that WT pHLIP
®
 peptide transfers from its monomeric form at <10 µM at pH 
8.0 to tetrameric oligomer at 50 µM and remains in the terameric form at high concentrations (at 
least up to 300 µM). At lower pH, WT pHLIP
®
 peptide formed much bigger aggregates which 
can also be approximately described by a cylinder scattering function but with very different 
aspect ratio. The model curve for pH 4 in Figure 3 corresponds to a mean radius of 14 nm with 
10% polydispersity and height of 5.4 nm. These parameters suggest that the pHLIP
®
 chains have 
further coiled and aggregated laterally to form a flat disk-like object at low pH.  
Next, we proceed to experiments on liposomes. Since spectral signals (especially CD) are 
destroyed by scattering from high concentration of liposomes (more than 4 mM of lipids), we 
 11 
prepared samples of 150 µM WT pHLIP
®
 peptide in State I (peptide at pH 8.0, no liposomes), 
State II (peptide at pH 8.0 and 4 mM POPC liposomes) and State III (peptide at pH 5.0 with 4 
mM POPC liposomes). Then, each sample was diluted 7 times and CD and fluorescence spectra 
were measured immediately. The changes of fluorescence signal (Figure 4) is typical for pHLIP
®
 
peptides (12, 19, 37) resulting in increase of fluorescence intensity and shift of the position of 
maximum of emission to shorter wavelengths, which is indicative of pH-dependent insertion into 
the lipid bilayer of membrane. CD demonstrates presence of exciton structures in the State I 
indicative of oligomerization (Figure 5). Also, the exciton signal was observed for the peptide in 
the presence of membrane at pH 8.0. We need to outline that at low lipid:peptide ratio (it is 27 in 
our case) we expect to have significant population of membrane unbound peptides, since at pH 
8.0 one peptide interacts with about 50 lipid head groups on average (28). At the same time, at 
low pH, the affinity of the peptide to membrane is higher and one peptide interacts with about 
10-15 lipids on average (28). As a result, the main population of peptides is in a membrane-
inserted, helical conformation, which is supported by the CD spectrum with minimum at 225 nm. 
In Figure 6, we present the SAXS from POPC vesicles in the absence and presence of WT 
pHLIP
®
 peptide. Because of the cancelling effect of positive and negative contrasts from the 
lipid head group and hydrophobic chains, respectively, the net low q forward scattering from 
pure POPC vesicles is rather weak and barely measurable over the buffer and instrument 
background. The main feature in SAXS is the bilayer form factor, which can be described by   
Eq. (4) confirming the unilamellar nature of the liposomes with mean radius about 28.5 nm. 
There is no significant variation in the bilayer form factor with pH and shape of the curves. The 
best fit excess electron density profiles using Eqs. (3) and (4) are displayed in Figure 7. As 
expected, the membrane electron density profiles of pure POPC liposomes perfectly superimpose 
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at higher and lower pH values. The same scattering features are observed at lower POPC 
concentrations with factor 2 and 4 dilutions but the intensity statistics at high q values become 
poorer. The obtained electron density profile of POPC unilamellar liposomes is comparable to 
that reported for oriented lipid membranes (32, 42) though less structured [for a similar model as 
in Eq. (3)] presumably due to shape fluctuations.  
With the addition of WT pHLIP
®
 peptide, the low q scattering features of POPC vesicles 
became more pronounced as a result of an increase in the positive contrast of the phospholipid 
membrane. Indeed, these low q scattering features are different from the pure peptide scattering 
profiles presented in Figure 3. At pH 8.0 a fraction of the peptides remained free in the solution. 
In Equation (4), it was necessary to include either a constant background or a fraction of free 
peptide (up to 30%) intensity to obtain a complete description of the data. However, at low pH in 
presence of membrane, larger peptide aggregates as that depicted in Figure 3 could not be 
observed, since most of the peptides were inserted into the membrane. The SAXS data are in 
agreement with CD measurements. Main parameters of the SAXS model are tabulated in Table 
2.  
At low pH, typical unilamellar liposome scattering signature became more evident confirming 
that WT pHLIP
®
 peptide has inserted into the membrane thereby significantly enhancing the 
positive contrast of the membranes. Scattering curves with peptide were analyzed using the same 
parameters of the unilamellar liposomes but the membrane electron density profile was allowed 
to vary. The corresponding excess electron density profiles are shown in Figure 7. At higher pH 
(pH 8.0), the inner hydrophibic part has similar shape as the pure POPC liposomes indicating the 
peptide molecules were residing at the outer leaflets of the membranes. This has led to an 
increase in the electron density of the head group region without significant broadening of the 
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peak implying that peptide chains have penetrated into the head group region. However, at lower 
pH (pH 5.0) both the inner and outer electron densities have increased meaning that the peptides 
have been inserted across the bilayer of the membrane. In addition, the peak at the outer 
hydrophilic part has significantly broadened implying that both ends of the peptide imposing 
steric constraints on the lipid head groups. The resulting enhanced electron density led to 
stronger low q scattering feature of the unilamellar liposomes.           
 
Discussion 
The pHLIP
®
 peptides find wide application in biomedical sciences (16, 21, 22, 43, 44) and, 
also, they prove to be very convenient model system for the investigation of a polypeptide 
insertion into lipid bilayer of membrane triggered by pH (12, 28, 30). While various 
spectroscopic methods employed previously probed changes to the conformation of peptide, 
SAXS employed in this study allowed us, for the first time, to monitor the changes to the 
liposome and lipid bilayer structure. Until now, most experiments were carried out at low peptide 
concentration (about 2 – 10 µM) and high lipid:peptide ratios (about 100 – 300). In this study we 
used high peptide concentration (about 150 – 300 µM) and low lipid:peptide ratio (about 30). 
First we investigated WT pHLIP
®
 peptide conformational states in solution in absence of 
liposomes at high and low pH. Interestingly that at the range of concentrations from 50 µM up to 
300 µM peptides remained in tetrameric configuration and does not form larger aggregates at pH 
8. It is a very important finding related to potential medical applications, when high dosage of 
pHLIP
®
 peptides could be required for human administration. At low pH, when Asp and Glu 
residues are protonated, peptide in solution in absence of liposomes forms higher order of 
aggregates. However, in the presence of membrane these larger aggregates were not observed at 
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low pH. The interaction of WT pHLIP
®
 peptide with liposomes has not altered the unilamellar 
vesicle structure upon peptide adsorption by lipid bilayer at high pH or upon insertion across the 
bilayer at low pH. From the analysis of SAXS data, an average change in the electron density 
profile of the membrane upon insertion of WT pHLIP
®
 peptide was derived. It is clearly shown 
the insertion of the peptide into the membrane at lower pH corresponding to a significant 
increase in the electron density and low q scattering. The membrane electron density profiles of 
POPC unilamellar vesicles without peptides are comparable to those reported in the literature for 
oriented POPC membranes (32, 42). Although, the model could be improved further with 
additional Gaussian terms in Eq. (3), it was sufficient to capture the main structural features of 
the POPC-WT pHLIP
®
 liposomes.  
Figure 8 schematically illustrates the behavior of the peptide in aqueous solution at low and 
high concentrations, and interactions with membrane at low and high pH values derived from 
numerous previous and current spectroscopic and SAXS studies. At high/neutral pH and at low 
concentration (< 7 µM), the peptide is monomeric in aqueous solution (37). With increase of 
peptide concentration (up to 30 µM), WT pHLIP
®
 peptide is associated into tetrameric oligomers 
and stays as a tetramer with concentration increase by about 10 fold (and potentially even higher 
concentrations). When excess of membrane is present, the equilibrium is shifted towards 
membrane-adsorbed state of the peptide (called state II). Depending on lipid:peptide ratio, 
polypeptide can adopt different conformations within a membrane. At low lipid:peptide ratios 
the “parking problem” exists, which results in partial adsorption of WT pHLIP® peptide by 
membrane, oppose to the extended peptide configuration at the surface of lipid bilayer at high 
lipid:peptide ratios (28). Also depending on hydrophobicity of the polypeptide sequence and 
presence of charged residues, various pHLIP
®
 peptides exhibit different penetration depths 
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within the bilayer (10, 45). Our data, obtained in this study, indicate that WT pHLIP
®
 peptide is 
adsorbed within the polar headgroup region of the bilayer. Drop of pH results in protonation of 
Asp/Glu residues, increase of overall polypeptide hydrophobicity, which triggers polypeptide 
partitioning into membrane and folding. Most of pHLIP
®
 peptides adopt very similar 
transmembrane helical orientation (called state III)(10). We have shown that at low peptide 
concentration transmembrane helices do not oligomerize (37). Our scattering data obtained on 
liposomes with WT pHLIP
®
 peptide at low pH suggest uniform distribution of helices at high 
peptide concentration and low lipid:peptide ratios. However, further investigation is required to 
address this question.   
The obtained results clearly indicate that SAXS could be used to monitor polypeptide 
interactions with lipid bilayer of membrane in real time upon pH change. Our next step will be a 
kinetic study directed toward monitoring changes of SAXS intensities upon peptide insertion into 
membrane and exit from the membrane with pH jumps in correlation with changes of tryptophan 
fluorescence signal of the peptide.   
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TABLES 
Table 1. Analysis of SAXS data obtained from 300 M solutions of WT pHLIP® peptide in PBS 
buffer at pH 8.0 and pH 5.0. Normalized SAXS intensities can be described by a polydisperse 
cylinder scattering function with parameters, mean radius (RC), height (HC), polydispersity in 
radius (pC), and a constant background (IB).  
pH RC (nm) HC (nm) pC IB (mm
-1
) 
8.0 1.37 6.4 0.1 4x10
-5
 
5.0 14.0 5.4 0.1 1x10
-4
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Table 2: Main parameters derived from SAXS modeling of data in Figure 6 by means of the 
separated form factor approach. Parameters RV, pV, H, C, DH, DC, XH, and IB represent mean 
vesicle radius, vesicle size polydispersity, excess electron densities of head group and 
hydrophobic chains, Gaussian widths of the head group and hydrophobic chains, distance to 
center of the head group from the bilayer midplane, and a constant background, respectively.   
 
  
Sample RV   
(nm) 
pV H 
(nm
-3
) 
C 
(nm
-3
) 
DH  
(nm) 
DC  
(nm) 
XH   
(nm) 
IB     
(mm
-1
) 
POPC-8.8mM pH 8.0 28.0 0.28 23.1 -23.2 0.36 0.66 1.8 7x10
-5 
POPC-8.8mM pH 5.0 28.0 0.28 22.5 -23.2 0.36 0.65 1.8 8x10
-5
 
POPC-4.4mM 
WT-150m pH 8.0 
28.6 0.30 26.3 -23.2 0.33 0.67 1.82 5x10
-5 
POPC-4.4mM 
WT 150m pH 5.0 
28.3 0.23 28.1 -20.7 0.48 0.94 1.8 8x10
-5
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FIGURES 
Figure 1. Tryptophan fluorescence excited at 295 nm of 150 µM of WT pHLIP® peptide in 
phosphate buffer at pH 8.0. 
Figure 2. Circular dichroism signal of 150 µM of WT pHLIP® peptide in phosphate buffer at pH 
8.0. 
Figure 3. Normalized SAXS intensities obtained from 300 µM solutions of WT pHLIP® peptide 
at pH 8.0 and pH 5.0. At pH 8.0, the scattering profile is described by a cylinder-like function 
corresponding to a tetrameric form of the peptide. At pH 5.0 in the absence of membrane, WT 
pHLIP
®
 peptide forms large flat aggregates. Table 1 summarizes the results of data analysis.   
Figure 4. Three states of WT pHLIP® peptide were monitored by changes of tryptophan 
fluorescence. The state I (black line) represents peptide in solution at pH 8.0. The state II (blue 
line) is a peptide in a solution in the presence of POPC liposomes at pH 8.0. The state III (red 
line) is a peptide in a solution in the presence of POPC liposomes at pH 5.0. 
Figure 5. Three states of WT pHLIP
®
 peptide were monitored by changes of CD signal. The state 
I (black line) represents peptide in solution at pH 8.0. The state II (blue line) is a peptide in a 
solution in the presence of POPC liposomes at pH 8.0. The state III (red line) is a peptide in a 
solution in the presence of POPC liposomes at pH 5.0. 
Figure 6. SAXS intensities from the POPC liposomes of nominal diameter 50 nm without and 
with WT pHLIP
®
 peptide. The low q region shows the unilamellar vesicle features while the 
high q region depicts the prototypical bilayer form factor. Data were analyzed using polydisperse 
unilamellar model with three Gaussian electron density profiles for the lipid bilayer using 
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Equations (3) and (4). Main parameters of the model are tabulated in Table 2. For clarity 
successive scattering curves have been multiplied by the factors indicated in parenthesis. 
Figure 7. Excess electron density profiles (above buffer level) presented as a sum of three 
Gaussian functions obtained from the analysis of SAXS intensities presented in Figure 6.     
Figure 8. Schematic presentation of WT pHLIP
®
 peptide interaction with lipid bilayer of 
membrane, see description in the text. 
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